LobbyingOatly lobbying by quarter
Oatly's latest lobbying report covers Q2 2026, at $110K. The four quarters Q4 2025–Q3 2026 total $340K. Its first report covers Q4 2022; the issues it reports most are Food Industry (Safety, Labeling, etc.) and Agriculture.
Oatly
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $340K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $30K | 1 |
| Q1 2023 | $30K | 1 |
| Q2 2023 | $30K | 1 |
| Q3 2023 | $40K | 2 |
| Q4 2023 | $100K | 2 |
| Q1 2024 | $150K | 2 |
| Q2 2024 | $120K | 2 |
| Q3 2024 | $130K | 2 |
| Q4 2024 | $130K | 2 |
| Q1 2025 | $120K | 2 |
| Q2 2025 | $120K | 2 |
| Q3 2025 | $120K | 2 |
| Q4 2025 | $120K | 2 |
| Q1 2026 | $110K | 2 |
| Q2 2026 | $110K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Food industry$563.3K · 23 reports
- Agriculture$508.3K · 22 reports
- Environment and Superfund$223.3K · 11 reports
- Trade$165K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES27 reports
- SENATE27 reports
- Agriculture, Dept of (USDA)6 reports
- Food & Drug Administration (FDA)6 reports
- Executive Office of the President (EOP)2 reports
- Centers For Disease Control & Prevention (CDC)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseOatly | $780K | 11 quarters |
| NVG | $570K | 12 quarters |
| Crossroads Strategies | $110K | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JOSHUA F. HURVITZ | Legislative Director, Rep. Anthony Weiner | Q2 2025 |
| IVELISSE ALEXANDRA PORROA-GARCIA | Policy Director, Congressional Hispanic Caucus (CHC); Legislative Assistant, Rep. Raul Ruiz; Staff Assistant, Sen. Barbara Boxer | Q2 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | NVG | $50K |
| 07/07for Q2 | In-house | $60K |
| 04/20for Q1 | NVG | $50K |
| 04/20for Q1 | In-house | $60K |
| 01/20for Q4 2025 | NVG | $50K |
| 01/15for Q4 2025 | In-house | $70K |
| 25/10/20for Q3 2025 | NVG | $50K |
| 25/10/17for Q3 2025 | In-house | $70K |
| 25/07/20for Q2 2025 | NVG | $50K |
| 25/07/16for Q2 2025 | In-house | $70K |
| 25/04/19for Q1 2025 | NVG | $50K |
| 25/04/16for Q1 2025 | In-house | $70K |
| 25/01/20for Q4 2024 | NVG | $50K |
| 25/01/16for Q4 2024 | In-house | $80K |
| 24/10/21for Q3 2024 | NVG | $50K |
| 24/10/17for Q3 2024 | In-house | $80K |
| 24/07/22for Q2 2024 | NVG | $50K |
| 24/07/19for Q2 2024 | In-house | $70K |
| 24/04/22for Q1 2024 | NVG | $50K |
| 24/04/16for Q1 2024 | In-house | $100K |